Skip to main content
Log in

Foam Sclerotherapy Using Polidocanol (Aethoxysklerol) for Preoperative Portal Vein Embolization in 16 Patients

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the clinical safety and effectiveness of foam sclerotherapy using polidocanol for preoperative portal vein embolization (PVE) before hemihepatectomy of the liver.

Materials and Methods

From March 2006 to October 2008, foam sclerotherapy using polidocanol was performed in 16 patients (male-to-female ratio of 12:4, age range 48–75 years [mean 62]) for PVE. Patients were diagnosed with Klatskin tumor (n = 13), gallbladder (GB) cancer (n = 2), or hepatocellular carcinoma (HCC) (n = 1). The foam was composed of a 1:2:1 ratio of 3% polidocanol (Aethoxysklerol; Kreussler Pharma, Wiesbaden, Germany), room air, and contrast media (Xenetix 350; Guerbet, Aulnay-Sous-Bois, France). The total amount of polidocanol used (2 to 8 mL [mean 4.6]) varied according to the volume of the target portal vein. We calculated the volume of future liver remnant (FLR) before and after PVE and evaluated complications associated with the use of polidocanol foam sclerotherapy for PVE.

Results

Technical success was achieved in all patients. All patients were comfortable throughout the procedure and did not experience pain during sclerotherapy. No periprocedural morbidity or mortality occurred. Patients underwent a liver dynamic computed tomography (CT) scan 2–4 weeks after PVE. FLR increased significantly after PVE using polidocanol foam from 19.3% (range 16–35%) before PVE to 27.8% (range 23–42%) after PVE (p = 0.001). All patients were operable for hemihepatectomy of the liver and achieved effective resection.

Conclusion

Foam sclerotherapy using polidocanol is clinically safe and effective for preoperative PVE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Liu H, Zhu S (2009) Present status and future perspectives of preoperative portal vein embolization. Am J Surg 197(5):686–690

    Article  PubMed  Google Scholar 

  2. Vetelainen R, Dinant S, van Vliet A et al (2006) Portal vein ligation is as effective as sequential portal vein and hepatic artery ligation in inducing contralateral liver hypertrophy in a rat model. J Vasc Interv Radiol 17(7):1181–1188

    Article  PubMed  Google Scholar 

  3. Aussilhou B, Lesurtel M, Sauvanet A et al (2008) Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 12(2):297–303

    Article  PubMed  CAS  Google Scholar 

  4. Yokoyama Y, Nagino M, Nimura Y (2007) Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 31(2):367–374

    Article  PubMed  CAS  Google Scholar 

  5. Makuuchi M, Thai BL, Takayasu K et al (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107(5):521–527

    PubMed  CAS  Google Scholar 

  6. Madoff DC, Abdalla EK, Vauthey JN (2005) Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 16(6):779–790

    PubMed  Google Scholar 

  7. Fazakas J, Mandli T, Ther G et al (2006) Evaluation of liver function for hepatic resection. Transplant Proc 38(3):798–800

    Article  PubMed  CAS  Google Scholar 

  8. Kakizawa H, Toyota N, Arihiro K et al (2006) Preoperative portal vein embolization with a mixture of gelatin sponge and iodized oil: efficacy and safety. Acta Radiol 47(10):1022–1028

    Article  PubMed  CAS  Google Scholar 

  9. Tsuda M, Kurihara N, Saito H et al (2006) Ipsilateral percutaneous transhepatic portal vein embolization with gelatin sponge particles and coils in preparation for extended right hepatectomy for hilar cholangiocarcinoma. J Vasc Interv Radiol 17(6):989–994

    Article  PubMed  Google Scholar 

  10. Matela J, Zabavnik Z, Jukic T et al (2005) Selective portal vein embolization as introduction in major surgery. Coll Antropol 29(1):163–167

    PubMed  Google Scholar 

  11. Madoff DC, Abdalla EK, Gupta S et al (2005) Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16(2 Pt 1):215–225

    PubMed  Google Scholar 

  12. Madoff DC, Gupta S, Pillsbury EP et al (2007) Transarterial versus transhepatic portal vein embolization to induce selective hepatic hypertrophy: a comparative study in swine. J Vasc Interv Radiol 18(1 Pt 1):79–93

    Article  PubMed  Google Scholar 

  13. Denys A, Lacombe C, Schneider F et al (2005) Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J Vasc Interv Radiol 16(12):1667–1674

    PubMed  Google Scholar 

  14. Di Stefano DR, de Baere T, Denys A et al (2005) Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology 234(2):625–630

    Article  PubMed  Google Scholar 

  15. Covey AM, Tuorto S, Brody LA et al (2005) Safety and efficacy of preoperative portal vein embolization with polyvinyl alcohol in 58 patients with liver metastases. AJR Am J Roentgenol 185(6):1620–1626

    Article  PubMed  Google Scholar 

  16. Gibo M, Unten S, Yogi A et al (2007) Percutaneous ipsilateral portal vein embolization using a modified four-lumen balloon catheter with fibrin glue: initial clinical experience. Radiat Med 25(4):164–172

    Article  PubMed  Google Scholar 

  17. Kaneko T, Nakao A, Takagi H (2002) Clinical studies of new material for portal vein embolization: comparison of embolic effect with different agents. Hepatogastroenterology 49(44):472–477

    PubMed  Google Scholar 

  18. Yamaki T, Nozaki M, Sasaki K (2000) Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 26(4):323–328

    Article  PubMed  CAS  Google Scholar 

  19. Jain R, Bandhu S, Sawhney S et al (2002) Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations. J Clin Ultrasound 30(7):416–423

    Article  PubMed  Google Scholar 

  20. Frullini A, Cavezzi A (2002) Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 28(1):11–15

    Article  PubMed  Google Scholar 

  21. Alos J, Carreno P, Lopez JA et al (2006) Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 31(1):101–107

    Article  PubMed  CAS  Google Scholar 

  22. Coleridge Smith P (2009) Foam and liquid sclerotherapy for varicose veins. Phlebology 24(Suppl 1):62–72

    Article  PubMed  Google Scholar 

  23. Madoff DC, Hicks ME, Vauthey JN et al (2002) Transhepatic portal vein embolization: anatomy, indications, and technical considerations. Radiographics 22(5):1063–1076

    PubMed  Google Scholar 

  24. Ferrero A, Vigano L, Polastri R et al (2007) Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg 31(8):1643–1651

    Article  PubMed  Google Scholar 

  25. Starzl TE, Francavilla A, Porter KA et al (1978) The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet 147(2):193–207

    PubMed  CAS  Google Scholar 

  26. Nagino M, Nimura Y, Kamiya J et al (1995) Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 21(2):434–439

    PubMed  CAS  Google Scholar 

  27. Lee HY, Kim SH, Lee JM et al (2006) Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239(1):113–121

    Article  PubMed  Google Scholar 

  28. Song TJ, Ip EW, Fong Y (2004) Hepatocellular carcinoma: current surgical management. Gastroenterology 127(5 Suppl 1):S248–S260

    Article  PubMed  Google Scholar 

  29. Cleary SP, Dawson LA, Knox JJ et al (2007) Cancer of the gallbladder and extrahepatic bile ducts. Curr Probl Surg 44(7):396–482

    Article  PubMed  Google Scholar 

  30. Marrocco-Trischitta MM, Guerrini P, Abeni D et al (2002) Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg 28(2):153–155

    Article  PubMed  Google Scholar 

  31. Grosse-Siestrup C, Unger V, Pfeffer J et al (2004) Hepatotoxic effects of polidocanol in a model of autologously perfused porcine livers. Arch Toxicol 78(12):697–705

    Article  PubMed  CAS  Google Scholar 

  32. Hamel-Desnos C, Desnos P, Wollmann JC et al (2003) Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 29(12):1170–1175

    Article  PubMed  Google Scholar 

  33. Mimura H, Fujiwara H, Hiraki T et al (2009) Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief. Eur Radiol 19(10):2474–2480

    Article  PubMed  Google Scholar 

  34. Guglielmi A, Ruzzenente A, Sandri M et al (2002) Risk assessment and prediction of rebleeding in bleeding gastroduodenal ulcer. Endoscopy 34(10):778–786

    Article  PubMed  CAS  Google Scholar 

  35. Kaneko T, Nakao A, Takagi H (2000) Experimental studies of new embolizing material for portal vein embolization. Hepatogastroenterology 47(33):790–794

    PubMed  CAS  Google Scholar 

  36. Kim MJ, Choo SW, Do YS et al (2004) Use of double-occlusion balloon catheter: preoperative portal vein embolization for induction of future remnant liver hypertrophy. Cardiovasc Intervent Radiol 27(1):16–20

    Article  PubMed  Google Scholar 

  37. Takayama T, Makuuchi M (2004) Preoperative portal vein embolization: is it useful? J Hepatobiliary Pancreat Surg 11(1):17–20

    Article  PubMed  Google Scholar 

  38. Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237(5):686–691 discussion 691-683

    PubMed  Google Scholar 

  39. Ji W, Liu WH, Ma KS et al (2003) Preoperative selective portal vein embolization in two-step hepatectomy for hepatocellular carcinoma in injured livers: a preliminary report. Hepatobiliary Pancreat Dis Int 2(2):216–220

    PubMed  Google Scholar 

  40. Vauthey JN, Chaoui A, Do KA et al (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127(5):512–519

    Article  PubMed  CAS  Google Scholar 

  41. de Baere T, Roche A, Elias D et al (1996) Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 24(6):1386–1391

    Article  PubMed  Google Scholar 

  42. de Baere T, Roche A, Vavasseur D et al (1993) Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery. Radiology 188(1):73–77

    PubMed  Google Scholar 

  43. Shimamura T, Nakajima Y, Une Y et al (1997) Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery 121(2):135–141

    Article  PubMed  CAS  Google Scholar 

  44. Wakabayashi H, Okada S, Maeba T et al (1997) Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: a preliminary report. Surg Today 27(5):403–410

    Article  PubMed  CAS  Google Scholar 

  45. Imamura H, Shimada R, Kubota M et al (1999) Preoperative portal vein embolization: an audit of 84 patients. Hepatology 29(4):1099–1105

    Article  PubMed  CAS  Google Scholar 

  46. Feied CF, Jackson JJ, Bren TS et al (1994) Allergic reactions to polidocanol for vein sclerosis. Two case reports. J Dermatol Surg Oncol 20(7):466–468

    PubMed  CAS  Google Scholar 

  47. Ko GY, Sung KB, Yoon HK et al (2003) Preoperative portal vein embolization with a new liquid embolic agent. Radiology 227(2):407–413

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kwang-Hun Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chung, SH., Lee, Ms., Kim, K.S. et al. Foam Sclerotherapy Using Polidocanol (Aethoxysklerol) for Preoperative Portal Vein Embolization in 16 Patients. Cardiovasc Intervent Radiol 34, 1236–1243 (2011). https://doi.org/10.1007/s00270-010-0079-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-010-0079-5

Keywords

Navigation